Product NDC: | 42794-018 |
Proprietary Name: | Liothyronine Sodium |
Non Proprietary Name: | Liothyronine Sodium |
Active Ingredient(s): | 5 ug/1 & nbsp; Liothyronine Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42794-018 |
Labeler Name: | SIGMAPHARM LABORATORIES, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA200295 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121130 |
Package NDC: | 42794-018-06 |
Package Description: | 1000 TABLET in 1 BOTTLE (42794-018-06) |
NDC Code | 42794-018-06 |
Proprietary Name | Liothyronine Sodium |
Package Description | 1000 TABLET in 1 BOTTLE (42794-018-06) |
Product NDC | 42794-018 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Liothyronine Sodium |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20121130 |
Marketing Category Name | ANDA |
Labeler Name | SIGMAPHARM LABORATORIES, LLC |
Substance Name | LIOTHYRONINE SODIUM |
Strength Number | 5 |
Strength Unit | ug/1 |
Pharmaceutical Classes | l-Triiodothyronine [EPC],Triiodothyronine [Chemical/Ingredient] |